These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 18945924)

  • 1. Allopurinol and nitric oxide activity in the cerebral circulation of those with diabetes: a randomized trial.
    Dawson J; Quinn T; Harrow C; Lees KR; Weir CJ; Cleland SJ; Walters MR
    Diabetes Care; 2009 Jan; 32(1):135-7. PubMed ID: 18945924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blunted response to systemic nitric oxide synthase inhibition in the cerebral circulation of patients with Type 2 diabetes.
    Nazir FS; Alem M; Small M; Connell JM; Lees KR; Walters MR; Cleland SJ
    Diabet Med; 2006 Apr; 23(4):398-402. PubMed ID: 16620268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide synthase inhibition in humans reduces cerebral blood flow but not the hyperemic response to hypercapnia.
    White RP; Deane C; Vallance P; Markus HS
    Stroke; 1998 Feb; 29(2):467-72. PubMed ID: 9472891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibition of nitric oxide synthase has an analgesic effect in chronic pain].
    Ashina M; Lassen LH; Bendtsen L; Jensen RA; Olesen J
    Ugeskr Laeger; 2000 Jan; 162(2):171-3. PubMed ID: 10647315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cerivastatin on forearm vascular responses, blood pressure responsiveness and ambulatory blood pressure in type 2 diabetic men.
    Tran D; Lowy A; Howes JB; Howes LG
    Diabetes Obes Metab; 2005 May; 7(3):273-81. PubMed ID: 15811145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of i.v. L-NG methylarginine hydrochloride (L-NMMA: 546C88) on basal and acetazolamide (Diamox) induced changes of blood velocity in cerebral arteries and regional cerebral blood flow in man.
    Lassen Lh; Sperling B; Andersen Ar; Olesen J
    Cephalalgia; 2005 May; 25(5):344-52. PubMed ID: 15839849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of nitric oxide to the blood pressure and arterial responses to exercise in humans.
    Campbell R; Fisher JP; Sharman JE; McDonnell BJ; Frenneaux MP
    J Hum Hypertens; 2011 Apr; 25(4):262-70. PubMed ID: 20505750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of nos inhibition on retinal arterial and capillary circulation in early arterial hypertension.
    Michelson G; WÃĪrntges S; Harazny J; Oehmer S; Delles C; Schmieder RE
    Retina; 2006 Apr; 26(4):437-44. PubMed ID: 16603964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of local vascular effects of the nitric oxide inhibitor NG-monomethyl-L-arginine on dorsal hand veins.
    Schindler C; Leuschner S; Schwanebeck U; Kirch W
    J Clin Pharmacol; 2012 Jun; 52(6):859-69. PubMed ID: 21566204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal production of nitric oxide (NO) and non-NO vasodilators in the forearm microcirculation in Type 2 diabetes: associations with blood pressure and HDL cholesterol.
    Woodman RJ; Playford DA; Watts GF
    Diabetes Res Clin Pract; 2006 Jan; 71(1):59-67. PubMed ID: 16029909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide-dependent endothelial function is unaffected by allopurinol in hypercholesterolaemic subjects.
    O'Driscoll JG; Green DJ; Rankin JM; Taylor RR
    Clin Exp Pharmacol Physiol; 1999 Oct; 26(10):779-83. PubMed ID: 10549401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylcholine acutely modifies nitric oxide synthase function in the human coronary circulation.
    Miner SE; Al-Hesayen A; Nield LE; Gori T; Parker JD
    Exp Physiol; 2010 Dec; 95(12):1167-76. PubMed ID: 20817701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cardiovascular angiotensin II type 1 receptor blockade on nitric oxide synthase inhibition in patients with insulin resistance syndrome.
    Brillante DG; O'Sullivan AJ; Brillante RE; Howes LG
    Blood Press; 2009; 18(3):142-8. PubMed ID: 19462315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of allopurinol on the cerebral vasculature of patients with subcortical stroke; a randomized trial.
    Dawson J; Quinn TJ; Harrow C; Lees KR; Walters MR
    Br J Clin Pharmacol; 2009 Nov; 68(5):662-8. PubMed ID: 19916990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lowering serum urate does not improve endothelial function in patients with type 2 diabetes.
    Waring WS; McKnight JA; Webb DJ; Maxwell SR
    Diabetologia; 2007 Dec; 50(12):2572-9. PubMed ID: 17928991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal.
    Calver A; Collier J; Moncada S; Vallance P
    J Hypertens; 1992 Sep; 10(9):1025-31. PubMed ID: 1328361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial blockade of nitric oxide synthase blunts the exercise-induced increase of von Willebrand factor antigen and of factor VIII in man.
    Jilma B; Dirnberger E; Eichler HG; Matulla B; Schmetterer L; Kapiotis S; Speiser W; Wagner OF
    Thromb Haemost; 1997 Oct; 78(4):1268-71. PubMed ID: 9364996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AT1 receptor blockade prevents the decrease in conduit artery flow-mediated dilatation during NOS inhibition in humans.
    Bellien J; Iacob M; Eltchaninoff H; Bourkaib R; Thuillez C; Joannides R
    Clin Sci (Lond); 2007 Jun; 112(7):393-401. PubMed ID: 17125466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a nitric oxide synthase inhibitor on pressor response to angiotensin II in conscious rats.
    Maeda T; Yoshimura T; Ohshige A; Koyama H; Ito M; Okamura H
    Artery; 1998; 23(1):1-9. PubMed ID: 10846613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous nitric oxide in the control of esophageal motility in humans.
    Konturek JW; Thor P; Lukaszyk A; Gabryelewicz A; Konturek SJ; Domschke W
    J Physiol Pharmacol; 1997 Jun; 48(2):201-9. PubMed ID: 9223025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.